Article
GP2-enriched pancreatic progenitors give rise to functional beta cells <i>in vivo</i> and eliminate the risk of teratoma formation
2021-05-16
Abstract excerpt
<h4>Summary</h4> Human pluripotent stem cell (hPSC)-derived pancreatic progenitors (PPs) can be differentiated into beta-like cells in vitro and in vivo , and therefore have therapeutic potential for type 1 diabetes (T1D) treatment. However, the purity of PPs varies across different hPSC lines, differentiation protocols and laboratories. The uncommitted cells may give rise to non-pancreatic endodermal, mesoderm...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 12409fda-269e-58b2-b926-874de94f0d66
- DOI
- 10.1101/2021.05.15.444293
